Arcellx (ACLX)

• Market cap: $6.57B
• 1 day: -0.05%
• 5 days: 70.39%
• 1 month: 65.86%
• 3 months: 55.22%
• 6 months: 62.66%
• Year to date: 79.51%
• 1 year: 88.68%
• 5 years: 576.79%
• 10 years: 576.79%
• Sector: Healthcare
• Industry: Biotechnology

About: Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Employees: 163